RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: thymoma
Accession: DOID:3275
browse the term
Definition: A thymus cancer that derives_from epithelial cells located_in the thymus. The tumor cells in a thymoma look similar to the normal cells of the thymus, grow slowly, and rarely spread beyond the thymus. (DO)
Synonyms: exact_synonym: thymomas
primary_id: MESH:D013945
xref: EFO:1000581 ; ICDO:8580/3; NCI:C198577 ; NCI:C3411
For additional species annotation, visit the
Alliance of Genome Resources .
Please select species to view GViewer data.
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
N
Aqp4
aquaporin 4
ISO
associated with Myasthenia Gravis
RGD
PMID:20728226
RGD:5148025
NCBI chrNW_004624770:5,581,192...5,593,470
Ensembl chrNW_004624770:5,580,808...5,594,628
G
G
AQP4
aquaporin 4
ISO
associated with Myasthenia Gravis
RGD
PMID:20728226
RGD:5148025
NCBI chr18:53,729,143...53,742,916
Ensembl chr18:53,729,186...53,743,156
G
P
AQP4
aquaporin 4
ISO
associated with Myasthenia Gravis
RGD
PMID:20728226
RGD:5148025
NCBI chr 6:111,407,632...111,422,169
Ensembl chr 6:111,407,639...111,422,109
G
S
Aqp4
aquaporin 4
ISO
associated with Myasthenia Gravis
RGD
PMID:20728226
RGD:5148025
NCBI chrNW_004936550:5,931,201...5,943,999
Ensembl chrNW_004936550:5,931,194...5,941,354
G
D
AQP4
aquaporin 4
ISO
associated with Myasthenia Gravis
RGD
PMID:20728226
RGD:5148025
NCBI chr 7:61,855,617...61,868,953
Ensembl chr 7:61,855,744...61,865,089
G
B
AQP4
aquaporin 4
ISO
associated with Myasthenia Gravis
RGD
PMID:20728226
RGD:5148025
NCBI chr18:20,108,607...20,122,381
Ensembl chr18:23,713,146...23,726,919
G
C
Aqp4
aquaporin 4
ISO
associated with Myasthenia Gravis
RGD
PMID:20728226
RGD:5148025
NCBI chrNW_004955772:1,160...10,709
Ensembl chrNW_004955772:1,159...10,709
G
R
Aqp4
aquaporin 4
ISO
associated with Myasthenia Gravis
RGD
PMID:20728226
RGD:5148025
NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,507,903...6,524,856
G
M
Aqp4
aquaporin 4
ISO
associated with Myasthenia Gravis
RGD
PMID:20728226
RGD:5148025
NCBI chr18:15,522,451...15,544,039
Ensembl chr18:15,522,553...15,544,039
G
H
AQP4
aquaporin 4
IEP
associated with Myasthenia Gravis
RGD
PMID:20728226
RGD:5148025
NCBI chr18:26,852,038...26,865,803
Ensembl chr18:26,852,043...26,865,771
G
N
Bap1
BRCA1 associated deubiquitinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chrNW_004624822:4,809,489...4,818,514
Ensembl chrNW_004624822:4,809,405...4,818,515
G
G
BAP1
BRCA1 associated deubiquitinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr22:13,765,510...13,774,866
Ensembl chr22:13,764,686...13,774,740
G
P
BAP1
BRCA1 associated deubiquitinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr13:34,544,570...34,553,538
Ensembl chr13:34,544,581...34,553,483
G
S
Bap1
BRCA1 associated deubiquitinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chrNW_004936473:3,239,009...3,247,806
Ensembl chrNW_004936473:3,239,010...3,247,806
G
D
BAP1
BRCA1 associated deubiquitinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr20:37,355,499...37,364,298
Ensembl chr20:37,355,494...37,511,125
G
B
BAP1
BRCA1 associated deubiquitinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr 3:52,344,067...52,352,187
Ensembl chr 3:53,573,785...53,581,943
G
C
Bap1
BRCA1 associated deubiquitinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chrNW_004955430:2,391,970...2,400,645
Ensembl chrNW_004955430:2,390,524...2,400,645
G
R
Bap1
BRCA1 associated deubiquitinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr16:6,453,126...6,461,952
Ensembl chr16:6,446,709...6,455,535
G
M
Bap1
Brca1 associated protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr14:30,973,358...30,981,887
Ensembl chr14:30,973,407...30,981,901
G
H
BAP1
BRCA1 associated deubiquitinase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr 3:52,401,008...52,410,008
Ensembl chr 3:52,401,008...52,410,008
G
N
Birc2
baculoviral IAP repeat containing 2
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chrNW_004624878:476,460...514,637
G
G
BIRC2
baculoviral IAP repeat containing 2
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr 1:93,721,449...93,746,638
G
S
Birc2
baculoviral IAP repeat containing 2
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chrNW_004936551:5,515,904...5,535,864
G
D
BIRC2
baculoviral IAP repeat containing 2
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr 5:29,294,080...29,314,837
Ensembl chr 5:29,294,692...29,312,771
G
B
BIRC2
baculoviral IAP repeat containing 2
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr11:97,298,736...97,324,966
Ensembl chr11:100,793,036...100,822,421
G
C
Birc2
baculoviral IAP repeat containing 2
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chrNW_004955412:5,658,322...5,685,628
Ensembl chrNW_004955412:5,659,478...5,685,114
G
R
Birc2
baculoviral IAP repeat-containing 2
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:4,968,842...4,988,732
G
M
Birc2
baculoviral IAP repeat-containing 2
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr 9:7,818,227...7,837,123
Ensembl chr 9:7,818,228...7,837,065
G
H
BIRC2
baculoviral IAP repeat containing 2
ameliorates
HEP
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr11:102,347,214...102,378,670
Ensembl chr11:102,347,211...102,378,670
G
N
Birc5
baculoviral IAP repeat containing 5
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chrNW_004624801:7,727,084...7,735,946
Ensembl chrNW_004624801:7,727,093...7,735,940
G
G
BIRC5
baculoviral IAP repeat containing 5
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr16:70,226,824...70,237,000
G
P
BIRC5
baculoviral IAP repeat containing 5
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr12:3,747,276...3,755,214
Ensembl chr12:3,747,279...3,755,215
G
S
Birc5
baculoviral IAP repeat containing 5
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chrNW_004936594:2,812,165...2,820,618
Ensembl chrNW_004936594:2,812,238...2,820,636
G
D
BIRC5
baculoviral IAP repeat containing 5
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr 9:2,930,308...2,959,307
G
B
BIRC5
baculoviral IAP repeat containing 5
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr17:72,292,332...72,303,493
Ensembl chr17:77,842,724...77,854,159
G
R
Birc5
baculoviral IAP repeat-containing 5
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380
G
M
Birc5
baculoviral IAP repeat-containing 5
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
G
H
BIRC5
baculoviral IAP repeat containing 5
ameliorates
HEP
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
G
N
Bsg
basigin (Ok blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36574092
NCBI chrNW_004624828:7,913,297...7,920,891
Ensembl chrNW_004624828:7,913,099...7,920,804
G
G
BSG
basigin (Ok blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36574092
NCBI chr 6:309,579...320,209
Ensembl chr 6:309,506...321,785
G
P
BSG
basigin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36574092
NCBI chr 2:77,735,586...77,743,451
G
S
Bsg
basigin (Ok blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36574092
NCBI chrNW_004936588:181,688...189,795
Ensembl chrNW_004936588:181,576...189,287
G
D
BSG
basigin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36574092
NCBI chr20:57,942,703...57,951,089
Ensembl chr20:57,943,276...57,951,061
G
B
BSG
basigin (Ok blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36574092
Ensembl chr19:539,815...551,456
G
C
Bsg
basigin (Ok blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36574092
NCBI chrNW_004955495:7,148,806...7,156,296
G
R
Bsg
basigin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36574092
NCBI chr 7:10,643,788...10,651,005
Ensembl chr 7:9,993,170...10,000,387
G
M
Bsg
basigin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36574092
NCBI chr10:79,540,192...79,547,813
Ensembl chr10:79,540,325...79,547,803
G
H
BSG
basigin (Ok blood group)
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:36574092
NCBI chr19:571,283...583,493
Ensembl chr19:571,277...583,494
G
P
CDKN2A
cyclin dependent kinase inhibitor 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr 1:200,774,496...200,799,149
Ensembl chr 1:200,792,469...200,798,854
G
D
CDKN2A
cyclin dependent kinase inhibitor 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr11:41,223,316...41,226,056
Ensembl chr11:41,223,315...41,264,379
G
B
CDKN2A
cyclin dependent kinase inhibitor 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr 9:21,803,862...21,831,322
G
R
Cdkn2a
cyclin-dependent kinase inhibitor 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:103,984,949...104,003,149
G
M
Cdkn2a
cyclin dependent kinase inhibitor 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
G
H
CDKN2A
cyclin dependent kinase inhibitor 2A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr 9:21,967,752...21,995,324
Ensembl chr 9:21,967,752...21,995,301
G
N
Cyld
CYLD lysine 63 deubiquitinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chrNW_004624757:5,895,912...5,953,485
G
G
CYLD
CYLD lysine 63 deubiquitinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr 5:36,541,022...36,600,874
Ensembl chr 5:36,541,764...36,595,417
G
P
CYLD
CYLD lysine 63 deubiquitinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr 6:34,058,091...34,121,939
Ensembl chr 6:34,059,081...34,121,264
G
S
Cyld
CYLD lysine 63 deubiquitinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chrNW_004936475:3,750,917...3,812,118
Ensembl chrNW_004936475:3,750,882...3,812,118
G
D
CYLD
CYLD lysine 63 deubiquitinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr 2:64,561,684...64,628,829
Ensembl chr 2:64,562,503...64,628,175
G
B
CYLD
CYLD lysine 63 deubiquitinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr16:31,004,393...31,064,546
Ensembl chr16:49,882,751...49,942,629
G
C
Cyld
CYLD lysine 63 deubiquitinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chrNW_004955433:8,788,867...8,845,925
Ensembl chrNW_004955433:8,788,655...8,845,925
G
R
Cyld
CYLD lysine 63 deubiquitinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr19:34,487,491...34,547,311
Ensembl chr19:18,314,019...18,373,658
G
M
Cyld
CYLD lysine 63 deubiquitinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr 8:89,423,506...89,478,574
Ensembl chr 8:89,423,675...89,478,573
G
H
CYLD
CYLD lysine 63 deubiquitinase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr16:50,742,086...50,801,935
Ensembl chr16:50,742,050...50,801,935
G
N
Dnmt3b
DNA methyltransferase 3 beta
susceptibility
ISO
associated with Myasthenia Gravis;DNA:SNP:promoter: -579G>T(human)
RGD
PMID:24260492
RGD:9589098
NCBI chrNW_004624842:6,450,972...6,505,929
Ensembl chrNW_004624842:6,450,852...6,475,785
G
G
DNMT3B
DNA methyltransferase 3 beta
susceptibility
ISO
associated with Myasthenia Gravis;DNA:SNP:promoter: -579G>T(human)
RGD
PMID:24260492
RGD:9589098
NCBI chr 2:37,128,635...37,176,033
Ensembl chr 2:37,146,538...37,174,570
G
P
DNMT3B
DNA methyltransferase 3 beta
susceptibility
ISO
associated with Myasthenia Gravis;DNA:SNP:promoter: -579G>T(human)
RGD
PMID:24260492
RGD:9589098
NCBI chr17:36,345,715...36,386,076
Ensembl chr17:36,345,816...36,386,072
G
S
Dnmt3b
DNA methyltransferase 3 beta
susceptibility
ISO
associated with Myasthenia Gravis;DNA:SNP:promoter: -579G>T(human)
RGD
PMID:24260492
RGD:9589098
NCBI chrNW_004936485:19,547,836...19,570,716
G
D
DNMT3B
DNA methyltransferase 3 beta
susceptibility
ISO
associated with Myasthenia Gravis;DNA:SNP:promoter: -579G>T(human)
RGD
PMID:24260492
RGD:9589098
NCBI chr24:22,096,386...22,123,378
Ensembl chr24:22,096,349...22,122,900
G
B
DNMT3B
DNA methyltransferase 3 beta
susceptibility
ISO
associated with Myasthenia Gravis;DNA:SNP:promoter: -579G>T(human)
RGD
PMID:24260492
RGD:9589098
NCBI chr20:29,049,993...29,096,957
Ensembl chr20:30,186,069...30,215,487
G
C
Dnmt3b
DNA methyltransferase 3 beta
susceptibility
ISO
associated with Myasthenia Gravis;DNA:SNP:promoter: -579G>T(human)
RGD
PMID:24260492
RGD:9589098
NCBI chrNW_004955422:28,380,595...28,427,012
Ensembl chrNW_004955422:28,380,591...28,421,301
G
R
Dnmt3b
DNA methyltransferase 3 beta
susceptibility
ISO
associated with Myasthenia Gravis;DNA:SNP:promoter: -579G>T(human)
RGD
PMID:24260492
RGD:9589098
NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:142,130,592...142,169,124
G
M
Dnmt3b
DNA methyltransferase 3B
susceptibility
ISO
associated with Myasthenia Gravis;DNA:SNP:promoter: -579G>T(human)
RGD
PMID:24260492
RGD:9589098
NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650
G
H
DNMT3B
DNA methyltransferase 3 beta
susceptibility
IAGP
associated with Myasthenia Gravis;DNA:SNP:promoter: -579G>T(human)
RGD
PMID:24260492
RGD:9589098
NCBI chr20:32,762,385...32,809,356
Ensembl chr20:32,762,385...32,809,359
G
P
LOC100622859
baculoviral IAP repeat-containing protein 2
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr 9:33,041,592...33,062,865
Ensembl chr 9:33,041,663...33,062,854
G
N
Naip
NLR family apoptosis inhibitory protein
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chrNW_004624905:437,799...485,774
G
G
NAIP
NLR family apoptosis inhibitory protein
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr 4:65,693,044...65,742,527
G
P
NAIP
NLR family apoptosis inhibitory protein
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr16:47,700,869...47,710,036
G
S
Naip
NLR family apoptosis inhibitory protein
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chrNW_004936549:5,000,526...5,069,110
G
B
NAIP
NLR family apoptosis inhibitory protein
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr 5:44,345,623...44,401,358
Ensembl chr 5:45,920,125...45,973,937
G
C
Naip
NLR family apoptosis inhibitory protein
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chrNW_004955575:249,659...283,378
G
H
NAIP
NLR family apoptosis inhibitory protein
ameliorates
HEP
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr 5:70,968,166...71,025,339
Ensembl chr 5:70,968,166...71,025,339
G
M
Naip2
NLR family, apoptosis inhibitory protein 2
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr13:100,280,571...100,338,630
Ensembl chr13:100,280,571...100,338,600
G
R
Naip6
NLR family, apoptosis inhibitory protein 6
ameliorates
ISO
mRNA:increased expression:thymus (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr 2:33,241,520...33,293,184
Ensembl chr 2:31,507,424...31,570,542
G
N
Pbrm1
polybromo 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chrNW_004624822:4,529,350...4,666,714
Ensembl chrNW_004624822:4,529,007...4,663,165
G
G
PBRM1
polybromo 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr22:13,914,023...14,059,221
Ensembl chr22:13,913,285...14,055,254
G
P
PBRM1
polybromo 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr13:34,689,718...34,821,117
Ensembl chr13:34,689,726...34,820,952
G
S
Pbrm1
polybromo 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chrNW_004936473:3,382,618...3,476,049
Ensembl chrNW_004936473:3,382,260...3,476,052
G
D
PBRM1
polybromo 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr20:37,110,437...37,231,676
Ensembl chr20:37,110,766...37,229,203
G
B
PBRM1
polybromo 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr 3:52,487,083...52,626,418
Ensembl chr 3:53,718,051...53,850,146
G
C
Pbrm1
polybromo 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chrNW_004955430:2,536,086...2,671,094
Ensembl chrNW_004955430:2,536,086...2,670,617
G
R
Pbrm1
polybromo 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr16:6,219,933...6,319,336
Ensembl chr16:6,213,300...6,311,780
G
M
Pbrm1
polybromo 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr14:30,741,095...30,843,549
Ensembl chr14:30,741,095...30,843,549
G
H
PBRM1
polybromo 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr 3:52,545,367...52,685,913
Ensembl chr 3:52,545,352...52,685,917
G
N
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chrNW_004624786:10,266,316...10,282,664
Ensembl chrNW_004624786:10,263,518...10,271,218
G
G
TP53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr16:7,047,686...7,065,567
Ensembl chr16:7,045,146...7,066,223
G
P
TP53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818
G
S
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chrNW_004936595:919,807...935,367
Ensembl chrNW_004936595:919,428...925,425
G
D
TP53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr 5:32,561,406...32,565,149
Ensembl chr 5:32,560,598...32,574,109
G
B
TP53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr17:7,699,449...7,717,812
Ensembl chr17:7,684,922...7,706,120
G
C
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chrNW_004955467:9,241,391...9,256,716
Ensembl chrNW_004955467:9,252,130...9,255,928
G
R
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
H
TP53
tumor protein p53
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
G
M
Trp53
transformation related protein 53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24974848
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all